Log in to save to my catalogue

Identification of drug-specific public TCR driving severe cutaneous adverse reactions

Identification of drug-specific public TCR driving severe cutaneous adverse reactions

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_38d2c02fdc28404082a384a33f386ffd

Identification of drug-specific public TCR driving severe cutaneous adverse reactions

About this item

Full title

Identification of drug-specific public TCR driving severe cutaneous adverse reactions

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2019-08, Vol.10 (1), p.3569-13, Article 3569

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Drug hypersensitivity such as severe cutaneous adverse reactions (SCAR), including Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), could be life-threatening. Here, we enroll SCAR patients to investigate the T cell receptor (TCR) repertoire by next-generation sequencing. A public αβTCR is identified from the cytotoxic T lymphocy...

Alternative Titles

Full title

Identification of drug-specific public TCR driving severe cutaneous adverse reactions

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_38d2c02fdc28404082a384a33f386ffd

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_38d2c02fdc28404082a384a33f386ffd

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-019-11396-2

How to access this item